Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

European Heart Journal(2012)10.1093/eurheartj/ehs104Source: DataRank Database

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC is a research paper published in European Heart Journal (2012). On theSindex it has a DataRank of 1.3. It has been cited 6,898 times.

N/A

1.3DataRank · unranked

Scored on demand from live citation data

Open Access6,898 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 540.52)OA: closedTopics (61)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

1.3

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (108)

J. J. V. McMurray,S. Adamopoulos,S. D. Anker,M. Bohm,V. Falk

Live enrichment

PubMed:22611136 OpenAlex:https://openalex.org/W2148910374

FWCI

540.52

Citation Percentile

1.0%

Citation Trend

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

closed

publisherhttps://academic.oup.com/eurheartj/article-pdf/33/14/1787/70578757/eurheartj_33_14_1787.pdf

journalhttps://doi.org/10.1093/eurheartj/ehs104

repositoryhttps://pubmed.ncbi.nlm.nih.gov/22611136

repositoryhttps://pubmed.ncbi.nlm.nih.gov/22828712

repositoryhttps://serval.unil.ch/notice/serval:BIB_11898AB8A634

Fields of Study

Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsCardiac pacing and defibrillation studiesAcute DiseaseAlgorithmsAnti-Arrhythmia AgentsArrhythmias, CardiacCardiac Imaging TechniquesCardiac Resynchronization TherapyCardiotonic AgentsChronic DiseaseClinical Laboratory TechniquesComorbidityDefibrillators, ImplantableDiureticsDrug CombinationsElectrocardiographyExercise TestFatty Acids, Omega-3Genetic TestingHeart FailureHumansNatriuretic PeptidesPrognosisStroke VolumeTerminology as TopicTherapies, InvestigationalThromboembolismVentricular Dysfunction, Left

MeSH Terms

Acute DiseaseAlgorithmsAnti-Arrhythmia AgentsArrhythmias, CardiacCardiotonic AgentsChronic DiseaseDiureticsDrug CombinationsElectrocardiographyExercise TestGenetic TestingHeart FailureHumansTerminology as TopicPrognosisStroke VolumeThromboembolismFatty Acids, Omega-3ComorbidityDefibrillators, ImplantableVentricular Dysfunction, LeftClinical Laboratory TechniquesTherapies, InvestigationalNatriuretic PeptidesCardiac Imaging TechniquesCardiac Resynchronization Therapy

Keywords

MedicineHeart failureTask forceCardiologyIntensive care medicineInternal medicine

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 2 of Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study

10.6084/m9.figshare.14478491.v1figshare

Additional file 2 of Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study

10.6084/m9.figshare.14478491figshare

Additional file 1 of Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study

10.6084/m9.figshare.14478488.v1figshare

Additional file 1 of Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study

10.6084/m9.figshare.14478488figshare

Additional file 1 of U-shaped association between plasma sphingosine-1-phosphate levels and mortality in patients with chronic systolic heart failure: a prospective cohort study

10.6084/m9.figshare.12432311.v1figshare

Additional file 1 of U-shaped association between plasma sphingosine-1-phosphate levels and mortality in patients with chronic systolic heart failure: a prospective cohort study

10.6084/m9.figshare.12432311figshare

Additional file 1 of Clinical outcomes after primary prevention defibrillator implantation are better predicted when the left ventricular ejection fraction is assessed by cardiovascular magnetic resonance

10.6084/m9.figshare.12560876.v1figshare

10.6084/m9.figshare.12560876figshare

Additional file 1 of The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders

10.6084/m9.figshare.12607244.v1figshare

Additional file 1 of The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders

10.6084/m9.figshare.12607244figshare

Additional file 2 of The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders

10.6084/m9.figshare.12607247.v1figshare

Additional file 2 of The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders

10.6084/m9.figshare.12607247figshare

Additional file 3 of The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders

10.6084/m9.figshare.12607250.v1figshare

Additional file 3 of The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders

10.6084/m9.figshare.12607250figshare

Additional file 4 of The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders

10.6084/m9.figshare.12607253.v1figshare

Additional file 4 of The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders

10.6084/m9.figshare.12607253figshare

Additional file 5 of The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders

10.6084/m9.figshare.12607256.v1figshare

Additional file 5 of The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders

10.6084/m9.figshare.12607256figshare

Additional file 1 of Kidney age - chronological age difference (KCD) score provides an age-adapted measure of kidney function

10.6084/m9.figshare.14490338.v1figshare

Additional file 1 of Kidney age - chronological age difference (KCD) score provides an age-adapted measure of kidney function

10.6084/m9.figshare.14490338figshare

Related Papers (10)

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

N/A

1.4DataRank · unranked

European Heart Journal(2012)

co-citedsame journal

10.1093/eurheartj/ehs092

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

N/A

1.3DataRank · unranked

BMJ(1998)

co-cited

10.1136/bmj.317.7160.703

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

N/A

1.4DataRank · unranked

Hypertension(2003)

co-cited

10.1161/01.hyp.0000107251.49515.c2

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

N/A

1.3DataRank · unranked

New England Journal of Medicine(2009)

co-cited

10.1056/nejmoa0904327

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

N/A

1.4DataRank · unranked

The Lancet(1998)

co-cited

10.1016/s0140-6736(98)07037-8

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

N/A

1.3DataRank · unranked

New England Journal of Medicine(1991)

co-cited

10.1056/nejm199108013250501

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

N/A

1.3DataRank · unranked

New England Journal of Medicine(2001)

co-cited

10.1056/nejmoa011161

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

N/A

1.3DataRank · unranked

New England Journal of Medicine(2005)

co-cited

10.1056/nejmoa043399

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

N/A

1.4DataRank · unranked

New England Journal of Medicine(1999)

co-cited

10.1056/nejm199909023411001

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

N/A

1.5DataRank · unranked

The Lancet(1998)

co-cited

10.1016/s0140-6736(98)07019-6